 |
|
Plasmapheresis in Refractory Generalized Myasthenia Gravis
Peter Kornfeld, MD;
Edward P. Ambinder, MD;
Thomas Mittag, PhD;
Adam N. Bender, MD;
Angelos E. Papatestas, MD;
Judith Goldberg, ScD;
Gabriel Genkins, MD
Arch Neurol. 1981;38(8):478-481.
Abstract
• A group of 16 patients with severe generalized myasthenia gravis (MG) (five with thymoma) that was resistant to anticholinesterases, thymectomy, and corticosteroids were treated by plasmapheresis. Twelve patients showed an excellent clinical response. Plasmapheresis is an effective treatment modality for many patients with severe generalized MG resistant to other forms of therapy. Unfortunately, the beneficial results are only transient and periodic plasmapheresis treatments are necessary.
Author Affiliations
From the Departments of Medicine (Drs Kornfeld and Genkins), Neoplastic Diseases (Dr Ambinder), Pharmacology (Dr Mittag), Neurology (Dr Bender), Surgery (Dr Papatestas), and Biostatistics (Dr Goldberg), Mount Sinai Medical Center, New York.
Footnotes
Accepted for publication March 14, 1981.
Reprint requests to 853 Fifth Ave, New York, NY 10021 (Dr Kornfeld).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Therapeutic Apheresis in Neurology Critical Care
Natarajan and Weinstein
J Intensive Care Med 2005;20:212-225.
ABSTRACT
Myasthenic Crisis: Response to Plasmapheresis Following Failure of Intravenous {gamma}-Globulin
Stricker et al.
Arch Neurol 1993;50:837-840.
ABSTRACT
Successful Plasmapheresis for Fulminant Myasthenia Gravis During Pregnancy
Levine and Keesey
Arch Neurol 1986;43:197-198.
ABSTRACT
Chronic Long-Interval Plasma Exchange in Myasthenia Gravis
Rodnitzky and Bosch
Arch Neurol 1984;41:715-717.
ABSTRACT
Plasmapheresis: Therapeutic or Experimental Procedure?
Dau
Arch Neurol 1984;41:647-653.
ABSTRACT
|
